{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:06:04Z","timestamp":1793279164386,"version":"4.5.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,9]]},"DOI":"10.1093\/ecco-jcc\/jjy087","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T15:10:43Z","timestamp":1529593843000},"page":"1249-1254","source":"Crossref","is-referenced-by-count":32,"title":["Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn\u2019s Disease: Results from IMAgINE 1 and IMAgINE 2"],"prefix":"10.1093","volume":"12","author":[{"given":"Frank M","family":"Ruemmele","sequence":"first","affiliation":[{"name":"Universit\u00e9 Sorbonne Paris Cit\u00e9, Paris Descartes, APHP H\u00f4pital Necker-Enfants Malades, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Rosh","sequence":"additional","affiliation":[{"name":"Goryeb Children\u2019s Hospital\/Atlantic Health, Morristown, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A","family":"Faubion","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla C","family":"Dubinsky","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Turner","sequence":"additional","affiliation":[{"name":"Shaare Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Lazar","sequence":"additional","affiliation":[{"name":"AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Eichner","sequence":"additional","affiliation":[{"name":"AbbVie Inc., North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Fue","family":"Maa","sequence":"additional","affiliation":[{"name":"AbbVie Inc., North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Alperovich","sequence":"additional","affiliation":[{"name":"AbbVie Inc., North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M","family":"Robinson","sequence":"additional","affiliation":[{"name":"AbbVie Inc., North Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S","family":"Hyams","sequence":"additional","affiliation":[{"name":"Connecticut Children\u2019s Medical Center, Hartford, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"key\n\t\t\t\t2018110910355532800_CIT0001","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Crohn\u2019s disease","volume":"380","author":"Baumgart","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0002","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2010.06.070","article-title":"Risk factors associated with progression to intestinal complications of Crohn\u2019s disease in a population-based cohort","volume":"139","author":"Thia","year":"2010","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0003","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3748\/wjg.v21.i5.1394","article-title":"Management of perianal fistulas in Crohn\u2019s disease: an up-to-date review","volume":"21","author":"Marzo","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0004","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ibd.21099","article-title":"Incidence of stricturing and penetrating complications of Crohn\u2019s disease diagnosed in pediatric patients","volume":"16","author":"Gupta","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0005","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","article-title":"Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn\u2019s disease","volume":"8","author":"Ruemmele","year":"2014","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0006","first-page":"33","article-title":"Management of complex perianal Crohn\u2019s disease","volume":"30","author":"Aguilera-Castro","year":"2017","journal-title":"Ann Gastroenterol"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0007","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0008","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn\u2019s disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0009","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/gut.2008.159251","article-title":"Adalimumab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"58","author":"Colombel","year":"2009","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/j.gastro.2012.04.046","article-title":"Safety and efficacy of adalimumab for moderate to severe Crohn\u2019s disease in children","volume":"143","author":"Hyams","year":"2012","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0011","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/MIB.0000000000001021","article-title":"Long-term efficacy and safety of adalimumab in pediatric patients with Crohn\u2019s disease","volume":"23","author":"Faubion","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0012","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00054725-200409000-00026","article-title":"C-reactive protein as a marker for inflammatory bowel disease","volume":"10","author":"Vermeire","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0013","first-page":"265","article-title":"Medical therapy of perianal Crohn\u2019s disease","volume":"31","author":"Klag","year":"2015","journal-title":"Viszeralmedizin"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: part 1: diagnosis and medical management","volume":"11","author":"Gomoll\u00f3n","year":"2017","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/2040622310368736","article-title":"The long-term risk of continuous immunosuppression using thioguanides in inflammatory bowel disease","volume":"1","author":"O\u2019Connor","year":"2010","journal-title":"Ther Adv Chronic Dis"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0016","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cgh.2009.01.004","article-title":"Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn\u2019s disease: a meta-analysis","volume":"7","author":"Siegel","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0017","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/MIB.0000000000000373","article-title":"Efficacy and safety of natalizumab and vedolizumab for the management of Crohn\u2019s disease: a systematic review and meta-analysis","volume":"21","author":"Chandar","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0018","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0019","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/2050640614550672","article-title":"Vedolizumab for inflammatory bowel disease: changing the game, or more of the same","volume":"2","author":"Raine","year":"2014","journal-title":"United European Gastroenterol J"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ibd.20788","article-title":"Efficacy of infliximab in pediatric Crohn\u2019s disease: a randomized multicenter open-label trial comparing scheduled to on demand maintenance","volume":"15","author":"Ruemmele","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0021","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00005176-200305000-00007","article-title":"A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (Remicade) in severe pediatric Crohn disease","volume":"36","author":"Cezard","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0022","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2036.2003.01672.x","article-title":"Response to infliximab is related to disease duration in paediatric Crohn\u2019s disease","volume":"18","author":"Lionetti","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0023","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00005176-200407000-00010","article-title":"Infliximab therapy in 30 patients with refractory pediatric Crohn disease with and without fistulas in The Netherlands","volume":"39","author":"de Ridder","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0024","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MPG.0b013e3181a70f21","article-title":"Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACH","volume":"49","author":"Crandall","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0025","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.mpg.0000237933.38223.da","article-title":"Infliximab in pediatric Crohn disease patients with enterovesicular fistulas","volume":"44","author":"Teitelbaum","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"key\n\t\t\t\t2018110910355532800_CIT0026","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/apt.12928","article-title":"Predictors of response to infliximab in paediatric perianal Crohn\u2019s disease","volume":"40","author":"Dupont-Lucas","year":"2014","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/12\/10\/1249\/26469443\/jjy087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T16:57:10Z","timestamp":1571504230000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/10\/1249\/5043154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,6,22]]},"published-print":{"date-parts":[[2018,11,9]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy087","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10]]},"published":{"date-parts":[[2018,6,22]]}}}